Trochanteric Bursitis Treatment & Management
- Author: Patrick M Foye, MD; Chief Editor: Sherwin SW Ho, MD more...
Acute Phase
Rehabilitation Program
Physical Therapy
Management of the patient during the acute phase can include icing of the affected regions for 20-30 minutes every 2-3 hours. The proper use of the various treatment modalities can be taught to patients during physical therapy sessions; subsequently, the patient can perform them independently. These modalities should be goal-directed as part of a comprehensive plan to facilitate active patient participation in the rehabilitation program.
The physical therapist can instruct the patient in a home exercise program, emphasizing stretching of the ITB and TFL and strengthening of the hip abductors, especially the gluteus medius. The use of phonophoresis and soft-tissue massage may also be helpful. Transcutaneous electrical nerve stimulation (TENS) can be considered in cases that prove resistant to the rehabilitation program.
Stretching of the ITB and TFL can be achieved with a program that incorporates passive adduction of the knee of the affected limb across the midline as far as possible and maintenance of this position for at least 10-20 seconds. This exercise can be repeated in various degrees of hip flexion, thus theoretically stretching the various ITB and TFL fibers. To avoid exacerbation of trochanteric bursitis (greater trochanteric pain syndrome, GTPS) and/or its symptoms, stretching should not be performed in a ballistic, jerking fashion. Instead, stretches should be performed in a controlled and sustained fashion.
Medical Issues/Complications
- Chronic pain
- Limited activity level
- Limping (antalgic gait)
- Sleep disturbance, which is especially problematic for patients who usually sleep on their sides
Surgical Intervention
Surgical intervention is generally not required for trochanteric bursitis (greater trochanteric pain syndrome, GTPS). Patients with this condition rarely need a bursectomy and partial resection of the greater trochanteric process.
Consultations
If the patient does not respond to appropriate treatments, or if the treating physician does not have the skill or supplies to perform corticosteroid injections, the patient may be referred to a musculoskeletal specialist. Usually, no other consultations are required.
Other Treatment
- Corticosteroid injection into the trochanteric bursa
- A mixture of a corticosteroid and a local anesthetic (eg, 40-80 mg of long-acting methylprednisolone [eg, Depo-Medrol; Pharmacia & Upjohn Co, Kalamazoo, Mich] and 5 mL of 1% lidocaine) can be injected into the affected trochanteric bursa with a 22-gauge needle.
- A 1.5-inch (3.8-cm) needle may be adequate for a slim patient. A heavier patient may require a 3.5-inch (8.9-cm) needle to reach the bursa.
- The needle is advanced to the greater trochanter and then is withdrawn slightly so that it is located within the bursa before the injection is made.
- Further specifics of the injection procedure and potential complications are beyond the scope of this text. Interested clinicians are encouraged to read other appropriate sources.
- Lievense et al found that, depending on the treatment setting, the rates of corticosteroid injections were 34% for primary care, 37% for specialist, and 34% for hospital, resulting in improvement rates between 60% 1-year follow-up and 66% at 5-year follow-up.[5] Patients who had received a corticosteroid injection had a 2.7-fold higher chance of recovery after 5 years relative to those patients who had not received such an injection. Having had a corticosteroid injection was predictive for improvement within 5 years.[5]
- Low-energy extracorporeal shock wave therapy
- Recent studies have shown that shock wave therapy is an effective treatment for greater trochanteric pain syndrome, especially for those who have high signal on MRI scans.[10, 11]
- A recent study showed that shock wave therapy led to a significantly better result than home exercises and corticosteroid injections.[12]
Recovery Phase
Rehabilitation Program
Physical Therapy
The physical therapy program should be advanced to include gradual resumption of sports-related activities.
Medical Issues/Complications
See Acute Phase, Medical Issues/Complications.
Other Treatment (Injection, manipulation, etc.)
Corticosteroid injections may be repeated, if necessary.
- Many authors and clinicians consider corticosteroid injections an important option within the comprehensive treatment plan for trochanteric bursitis (greater trochanteric pain syndrome, GTPS). A randomized, controlled clinical trial demonstrated that corticosteroid and lidocaine injection for trochanteric bursitis was an effective therapy with prolonged benefits.[13]
- Trochanteric bursa injections are commonly performed without any radiographic guidance. However, some preliminary data suggest that radiologic confirmation (eg, with fluoroscopy) is necessary for accurate trochanteric bursa injections, especially in the following patients with[14] :
- Heavy body habitus or obesity
- A history of repeated injections
- A history of chronic inflammation
- A history of previous surgery
- Pain for long periods, with the development of peripheral sensitization, which may lead to the injection of medicine into tender areas rather than the areas involved in pain generation
For a diagnostic injection, local anesthetic without epinephrine (eg, 5 mL of 1-2% lidocaine) can be injected into the affected trochanteric bursa with a 22-gauge needle. A 1.5-inch (3.8-cm) needle may be adequate for a slim patient, but a heavier patient may require a 3.5-inch (8.9-cm) needle to reach the bursa. The needle is advanced to the greater trochanter (making contact with the bone as confirmation of depth and appropriate placement) and then withdrawn slightly so that it is located within the bursa. The local anesthetic can then be injected directly into the bursa; if the patient receives appropriate pain relief, this is considered confirmation of trochanteric bursitis (greater trochanteric pain syndrome, GTPS) as the source of the pain.
- The injection of local anesthetic can be followed by the administration of steroids through the same needle; the syringe is then switched to one containing the corticosteroid. Injection of 40-80 mg of methylprednisolone acetate or triamcinolone acetonide should be adequate. This injection may be repeated after 4-6 weeks if pain relief has been less than 50%.
- In most cases (ie, the diagnosis of trochanteric bursitis (greater trochanteric pain syndrome, GTPS) seems straightforward from the clinical evaluation), a diagnostic injection (or local anesthetic injection) is not necessary before the corticosteroid injection. In these cases, the most straightforward approach is to perform the same needle approach as outlined above, followed by delivery of a mixture of a corticosteroid and a local anesthetic (eg, 40-80 mg of long-acting methylprednisolone [eg, Depo-Medrol] and 5 mL of 1% lidocaine).
- Further specifics of the injection procedure and potential complications are beyond the scope of this text. Interested clinicians are encouraged to read other appropriate sources.
Relative rest includes restriction of activities, such as climbing stairs or getting in and out of chairs. Direct pressure on the affected site should also be avoided.
Evaluation and correction of any underlying gait abnormalities are important and may be addressed with assistive devices (eg, cane, walker, orthotics, shoe lift, knee brace).
Use of deep-heating modalities (eg, US, TENS) should be considered in cases in which conventional therapy has failed in the patient (10-12 wk).
Maintenance Phase
Rehabilitation Program
Physical Therapy
Ideally, by the time the patient is on maintenance therapy, he or she is independently performing a home exercise program to prevent recurrence of trochanteric bursitis (greater trochanteric pain syndrome, GTPS).
Williams BS, Cohen SP. Greater trochanteric pain syndrome: a review of anatomy, diagnosis and treatment. Anesth Analg. May 2009;108(5):1662-70. [Medline].
Silva F, Adams T, Feinstein J, Arroyo RA. Trochanteric bursitis: refuting the myth of inflammation. J Clin Rheumatol. Apr 2008;14(2):82-6. [Medline].
Clarke MT, Arora A, Villar RN. Hip arthroscopy: complications in 1054 cases. Clin Orthop Relat Res. Jan 2003;406:84-8. [Medline].
Segal NA, Felson DT, Torner JC, et al. Greater trochanteric pain syndrome: epidemiology and associated factors. Arch Phys Med Rehabil. Aug 2007;88(8):988-92. [Medline].
Lievense A, Bierma-Zeinstra S, Schouten B, Bohnen A, Verhaar J, Koes B. Prognosis of trochanteric pain in primary care. Br J Gen Pract. Mar 2005;55(512):199-204. [Medline]. [Full Text].
Tibor LM, Sekiya JK. Differential diagnosis of pain around the hip joint. Arthroscopy. Dec 2008;24(12):1407-21. [Medline].
Kong A, Van der Vliet A, Zadow S. MRI and US of gluteal tendinopathy in greater trochanteric pain syndrome. Eur Radiol. Jul 2007;17(7):1772-83. [Medline].
Blankenbaker DG, Ullrick SR, Davis KW, et al. Correlation of MRI findings with clinical findings of trochanteric pain syndrome. Skeletal Radiol. Oct 2008;37(10):903-9. [Medline].
Fearon AM, Scarvell JM, Cook JL, Smith PN. Does ultrasound correlate with surgical or histologic findings in greater trochanteric pain syndrome? A pilot study. Clin Orthop Relat Res. Jul 2010;468(7):1838-44. [Medline]. [Full Text].
Furia JP, Rompe JD, Maffulli N. Low-energy extracorporeal shock wave therapy as a treatment for greater trochanteric pain syndrome. Am J Sports Med. Sep 2009;37(9):1806-13. [Medline].
Vannet N, Ferran N, Thomas A, Ghandour A, O'Doherty A. The use of shockwave therapy in the treatment of of trochanteric bursitis. J Bone Joint Surg Br Proceedings. Jul 2010;92-B:393. [Full Text].
Rompe JD, Segal NA, Cacchio A, Furia JP, Morral A, Maffulli N. Home training, local corticosteroid injection, or radial shock wave therapy for greater trochanter pain syndrome. Am J Sports Med. Oct 2009;37(10):1981-90. [Medline].
Shbeeb MI, O'Duffy JD, Michet CJ Jr, O'Fallon WM, Matteson EL. Evaluation of glucocorticosteroid injection for the treatment of trochanteric bursitis. J Rheumatol. Dec 1996;23(12):2104-6. [Medline].
Cohen SP, Narvaez JC, Lebovits AH, Stojanovic MP. Corticosteroid injections for trochanteric bursitis: is fluoroscopy necessary? A pilot study. Br J Anaesth. Jan 2005;94(1):100-6. [Medline]. [Full Text].
Hofmeister E, Engelhardt S. Necrotizing fasciitis as complication of injection into greater trochanteric bursa. Am J Orthop. May 2001;30(5):426-7. [Medline].
Brinker MR, Miller MD. The adult hip. Fundamentals of Orthopaedics. Philadelphia, Pa: WB Saunders Co; 1999:269-85.
Farmer KW, Jones LC, Brownson KE, Khanuja HS, Hungerford MW. Trochanteric bursitis after total hip arthroplasty: incidence and evaluation of response to treatment. J Arthroplasty. Feb 2010;25(2):208-12. [Medline].
Green SM, ed. Nonsteroidal anti-inflammatories. Tarascon Pocket Pharmacopoeia 2000. Loma Linda, Calif: Tarascon Publishing; 2000:11-2.
Lennard TA. Fundamentals of procedural care. Physiatric Procedures in Clinical Practice. Philadelphia, Pa: Hanley & Belfus; 1995:1-13.
McGee DJ. Hip. Orthopedic Physical Assessment. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1992:333-71.
Olsen NK, Press JM, Young JL. Bursal injections. Physiatric Procedures in Clinical Practice. Philadelphia, Pa: Hanley & Belfus; 1995:36-43.
Pretell J, Ortega J, Garcia-Rayo R, Resines C. Distal fascia lata lengthening: an alternative surgical technique for recalcitrant trochanteric bursitis. Int Orthop. Oct 2009;33(5):1223-7. [Medline].
Snider RK. Hip and thigh. Essentials of Musculoskeletal Care. 2nd ed. Rosemont, Ill: American Academy Orthopedic Surgeons; 1997:264-303.
Snider RK. Injection and corticosteroids. Essentials of Musculoskeletal Care. 2nd ed. Rosemont, Ill: American Academy Orthopedic Surgeons; 1997:37-9.
Steinberg JG, Seybold EA. Hip and pelvis. In: Steinberg GG, Akins CM, Baran DT, eds. Orthopaedics in Primary Care. 3rd ed. Baltimore, Md: Lippincott Williams & Wilkins; 1999:171-203.
Young JL, Olsen NK, Press JM. Musculoskeletal disorders of the lower limbs. In: Braddom RL, ed. Physical Medicine and Rehabilitation. Philadelphia, Pa: WB Saunders Co; 1996:783-812.

